Search clinical trials for: AMG
Total 2734 results
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedCat Allergy | Cat HypersensitivityUnited States
-
NantCell, Inc.CompletedSarcoma | Ewing's Sarcoma | Primitive Neuroectodermal Tumors (PNETs) | Askin's Tumors | Desmoplastic Small Round Cell Tumors | Estraosseous Ewing's Tumor | Ewing's Family Tumor
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Australia, Austria, Israel, Czechia, Hungary, Netherlands, Poland, France, Russian Federation, Sweden
-
Martin Andreas, M.D.National Bank of Austria; Orphan MedicalCompleted
-
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.Not yet recruiting
-
AmgenCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
AmgenTerminatedActive Systemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, Canada, Spain, Italy, Mexico, Japan, Turkey, Austria, Greece, Colombia, Switzerland, Poland, France, Bulgaria, Hong Kong, Russian Federation, Chile
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Thrombocytopenia | Refractory Multiple MyelomaUnited States
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
AmgenActive, not recruitingAtopic DermatitisKorea, Republic of, United States, Turkey, Hong Kong, United Kingdom, Australia, Brazil, Canada, Argentina
-
AmgenActive, not recruiting
-
Daewoong Pharmaceutical Co. LTD.CompletedT2DM (Type 2 Diabetes Mellitus)Korea, Republic of
-
AmgenTerminatedAdvanced Solid TumorsUnited States
-
Inovio PharmaceuticalsCompletedProstate CancerUnited States
-
Translational Research in OncologyTerminatedOvarian NeoplasmsUnited States, France, Germany, Israel, Ireland, Spain, Canada, United Kingdom
-
GlaxoSmithKlineCompletedAlzheimer's DiseaseUnited States, Australia, Spain, Bulgaria, Poland, Germany, Philippines, Singapore, Belgium, Canada, Hong Kong, Korea, Republic of, Finland, Slovenia, Czechia, France, South Africa, Sweden, Netherlands, Malaysia, United Kingdom, S...
-
AmgenCompletedCarcinoma | Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumors | Oncology | Tumors | Metastases | Gynecological MalignanciesBelgium, United States, Australia
-
AmgenCompleted
-
AmgenCompletedFracture HealingFinland, Italy, Sweden, United States, Belgium, Switzerland, Canada, Hong Kong, Hungary, Germany, Netherlands, Bulgaria, Australia, Poland, Greece, Denmark, United Kingdom, Estonia, India, New Zealand, Latvia, Lithuania, Argentina, Sl...
-
NantCell, Inc.CompletedPancreatic Cancer | Adenocarcinoma of the Pancreas | Metastatic Pancreatic CancerUnited States
-
AmgenCompleted
-
AmgenNot yet recruiting
-
AmgenRecruitingAtopic DermatitisUnited States, Korea, Republic of, Taiwan, Spain, Croatia, China, Greece, Belgium, Thailand, Puerto Rico, Hungary, Poland, Germany, Brazil, Italy, Japan, Canada, France, Romania, Chile
-
AmgenCompletedSecondary HyperparathyroidismChina
-
Bausch Health Americas, Inc.TerminatedPsoriasisUnited States, Australia, France, Canada, Denmark
-
Translational Research in OncologyCompletedStudy of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian CancerOvarian NeoplasmsUnited States, France, Ireland, Germany, Israel, Canada, Spain
-
Alexza Pharmaceuticals, Inc.CelerionCompleted
-
AmgenNot yet recruiting
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia
-
JW PharmaceuticalChonbuk National University Hospital; Samsung Medical Center; Asan Medical Center and other collaboratorsCompletedto Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (SIPHON)HbA1c Level Associated With Lipid CompositionsKorea, Republic of
-
Genor Biopharma Co., Ltd.RecruitingLymphoma | Advanced Solid Tumor | Recurrent Solid Tumor | Recurrent Lymphocyte Depleted Classical Hodgkin LymphomaChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Azza Mohamed Ahmed SaidAin Shams UniversityUnknown
-
AmgenCompletedMetastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal Cancer
-
AmgenCompletedCeliac DiseaseFinland
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
Sorrento Therapeutics, Inc.Withdrawn
-
Sorrento Therapeutics, Inc.Withdrawn
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
AmgenRecruitingAtopic DermatitisJapan, Korea, Republic of, United States, Taiwan, Spain, Germany, Croatia, China, Greece, Italy, Czechia, Brazil, Poland, Portugal, Slovakia, Argentina, Canada, Puerto Rico, Hungary, Latvia, Netherlands